By Betsy Jenkins, LCPC

In recent years, there has been much debate about the role of traditional therapy in psychedelic-assisted therapy. Some argue that the medicines are the primary agents of change, needing only minimal support from a therapist or facilitator. Others argue that the therapist plays a pivotal role in treatment efficacy and safety. As therapists, we are with patients throughout their entire journey—from preparing them before they take the drug, to being there during their dosing session, and then helping them integrate their experience afterwards. By creating a safe and comfortable environment, and providing a supportive and engaged presence, the therapist can and does have a significant impact on the outcome.

I believe the therapy element of this treatment is as important as the psychedelic compound.

The supportive presence, so necessary in psychedelic-assisted therapy, can be enhanced in a group setting. As humans, we are often driven by a quest for meaning and a need to bond with others. Psychedelics bring out a strong sense of love and connectivity and feelings of unity and peace—so being together with others having similar experiences should be helpful. However, most existing protocols for psychedelic-assisted therapies call for one-on-one patient-therapist sessions. Throughout my........

© Psychology Today